bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.03.24.644909

Molecular Mechanisms of Chinese Medicine in Regulating Colorectal Cancer Immune Microenvironment: Insights from Single-Cell Transcriptomics and Network Pharmacology

Abstract

BackgroundThe molecular mechanisms underlying the efficacy of Traditional Chinese Medicine (TCM) in colorectal cancer treatment remain largely unexplored. We developed a computational systems biology approach integrating single-cell transcriptomics with network pharmacology to elucidate the potential mechanisms of TCM in modulating colorectal cancer progression. MethodsWe developed an integrated computational pipeline for multi-omics data analysis combining single-cell transcriptomics with network pharmacology. Raw single-cell RNA-seq data from 3 normal tissues and 3 colorectal tumors were obtained from GEO database and processed using a customized workflow in R. Quality control, normalization, and dimensionality reduction were performed using the Seurat v4.0 algorithm, followed by unsupervised clustering to identify cell subpopulations. Differentially expressed genes (DEGs) were identified using MAST algorithm with adjusted p-value < 0.05 and |log2FC| > 1.0. These computationally identified DEGs were subsequently mapped to a comprehensive Traditional Chinese Medicine (TCM) database using a network pharmacology approach to predict herb-target interactions. In parallel, we integrated TCGA RNA-seq data (STAR-counts) with clinical information, applying log2(TPM+1) transformation for normalization. We then implemented a machine learning-based correlation analysis to construct gene-cell-immunity-pathway networks, using weighted gene co-expression network analysis (WGCNA) to identify key regulatory modules. ResultsOur computational analysis of single-cell RNA-seq data identified 109 differentially expressed genes (DEGs) that define the molecular signature of colorectal cancer microenvironment. Clustering algorithms revealed 14 distinct cell subpopulations, with predominant immune cell infiltration, particularly B and T lymphocytes, suggesting a complex immune regulatory network. Network pharmacology analysis mapped these DEGs to potential therapeutic targets, computationally predicting interactions with 140 traditional Chinese herbs. These herbs were classified into 8 functional categories. Through integrative multi-omics analysis and pathway enrichment algorithms, we identified core regulatory networks comprising 23 genes and 39 significantly enriched signaling pathways (FDR < 0.01) that orchestrate immune cell function in the tumor microenvironment. Notably, our analysis in silico revealed previously uncharacterized gene-pathway interactions that may explain the immunomodulatory effects of specific herbal compounds. ConclusionsOur systems biology and computational analysis revealed a potential mechanism by which 8 categories of Chinese herbal medicines and 23 genes across 39 signaling pathways may regulate colorectal cancer progression through modulation of specific gene regulatory networks and immune cell functions. These findings demonstrate the value of integrative computational approaches in elucidating complex biological mechanisms of traditional medicines

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhang, C., Zhang, Y., Li, P., Wang, Y., Guo, K.. 2025-03-27. Molecular Mechanisms of Chinese Medicine in Regulating Colorectal Cancer Immune Microenvironment: Insights from Single-Cell Transcriptomics and Network Pharmacology. https://doi.org/10.1101/2025.03.24.644909

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Common viral infections seed regionally distinct resident memory T cells in the human CNS

T cells persist in the central nervous system (CNS) and can drive both protection and neurological disease. How these cells are organized in humans and what they recognize is largely unknown. Here, we profiled CD8 T cells across anatomically distinct CNS regions, obtained through on-site autopsies and temporal lobe resection surgeries, using single-cell RNA sequencing, paired T cell receptor sequencing, and DNA-barcoded tetramers. Resident memory T cells (TRM) specific for Epstein-Barr virus, cytomegalovirus, influenza A, and SARS-CoV-2 were identified across CNS compartments. Anatomical location was the strongest correlate of TRM cell state, with leptomeningeal cells adopting a cytokine-poised TRM program, whereas brain TRM cells were transcriptionally restrained. Cells of the same clonotype spanned tissues yet adopted local transcriptional states. Viral specificity added another layer of TRM heterogeneity with GZMK/GZMA-expressing EBV-specific populations and interferon-stimulated gene signatures in SARS-CoV-2 and Influenza A-specific cells. The human CNS thus harbors regionally distinct CD8+ TRM shaped by common viral exposures.

immunology↗

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Transimmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios+ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4+ and CD45RA- Tregs. In RA specifically, LAG3+ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (<= years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic "window of opportunity" concept and duration-stratified Treg-directed trials.

immunology↗

Inhibitory Fc Receptor sets a time limit on macrophage response to IgG

Antibodies engage both activating Fc Receptors and the inhibitory receptor Fc{gamma}RIIB. Why macrophages need a dedicated inhibitory receptor rather than simply tuning activating receptor signaling is unclear. Using DNA-based chimeric receptors and in silico modeling, we independently controlled activating and inhibitory Fc Receptors. We found that Fc{gamma}RIIB imposed a time limit on macrophage phagocytosis and ERK signaling. The time limit is due to activating Fc Receptors converting PI(4,5)P2 to PI(3,4,5)P3, which is subsequently converted to PI(3,4)P2 by Fc{gamma}RIIB. This leads to a pulse of active signaling, which is sufficient for phagocytosis of small bacteria-sized targets but not phagocytosis of large targets and TNF secretion. Unlike engaging Fc{gamma}RIIB, reducing activating Fc Receptor signaling decreased initiation of phagocytosis, the speed of PI(3,4,5)P3 generation, and the amplitude of ERK signaling. Our results demonstrate that Fc{gamma}RIIB controls the duration of IgG signaling, while the activating Fc Receptors control sensitivity.

immunology↗